Black Patients More Likely to Experience MACE After ADT for Prostate Cancer
By Elana Gotkine HealthDay Reporter
THURSDAY, June 20, 2024 -- Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy (ADT) for prostate cancer, according to a study published online June 18 in JACC: CardioOncology.
Biniyam G. Demissei, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study involving 3,543 prostate cancer patients treated with systemic ADT between 2008 and 2021. The multivariable adjusted association between self-reported race (Black versus White) and incident major adverse cardiovascular events (MACE) after initiation of ADT was assessed.
The researchers found that the risk for MACE was increased in association with Black race (hazard ratio, 1.38), with the strongest associations seen for incident heart failure, cerebrovascular disease, and peripheral artery disease (hazard ratios, 1.79, 1.98, and 1.76, respectively). Overall, 98 percent of the disparity in MACE risk between Black and White patients was mediated by the social vulnerability index, specifically the socioeconomic status theme.
"Multilevel targeted interventions tailored to the needs of patients from socioeconomically vulnerable communities are necessary to reduce the disparities in CVD in patients with prostate cancer," the authors write.
One author disclosed ties to Pfizer.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Survival Improves With Open Hysterectomy for Cervical Cancer
FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical...
Precision-Guided Treatment Improves Outcomes for High-Risk Pediatric Cancer
FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June 6 in Nature Medicine. Loretta...
Recommendations Issued for Advanced Imaging for Pediatric Patients in ED
THURSDAY, June 27, 2024 -- In a policy statement issued by the American Academy of Pediatrics and published online June 27 in Pediatrics, recommendations are presented for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.